Charlie O’Connell is the founder and CEO of FITSCRIPT: a digital therapeutics company dedicated to providing digital exercise therapy to people living with diabetes around the globe.

Fitscript’s patented and clinically validated GlucoseZone ( offers patients A1c improvement and weight loss through digital exercise therapy based on their real time bio metrics and medication usage.
Fitscript is a company dedicated to providing on-demand and interactive multi-media guidance to the global diabetes community.

Thru June of 2019, over 1 million people living with diabetes around the world have utilized GLUCOSEZONE programming to reduce, manage, and control their diabetes.

Diagnosed with Type 1 diabetes in the fall of 1996, Charlie is a graduate of the University of Pennsylvania (’02). Charlie is a father, husband, golfer, skier, runner, speaker, inventor and entrepreneur, and lives in New Haven CT with his wife and two small children.